Match tier
Listed
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
A
Anna Mazur
Role not yet determined Is this you? Add your title
Also affiliated: University of Helsinki (2009); Washington University in St. Louis (2009); University of Arkansas Medical Center (2008); University Medical Center Hamburg-Eppendorf (2003); Arkansas Department of Health (2009); Marshall University (2024)
6 h-index
14 pubs
549 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Anna Mazur's research focuses on understanding and mitigating the toxicity of cryoprotectants, substances used to preserve biological tissues at low temperatures. Her work investigates how biological systems can be manipulated to reduce this toxicity. Recent publications in 2024 highlight the potential for inducing stress response pathways to significantly lower cryoprotectant toxicity. Mazur's scholarship metrics include an h-index of 7, with 15 total publications and 561 citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Robert J. Shmookler Reis, Srinivas Ayyadevara, and Nirjal Mainali, co-authoring two publications with each.
Metrics
- h-index: 6
- Publications: 14
- Citations: 549
Selected Publications
-
Model biological systems demonstrate the inducibility of pathways that strongly reduce cryoprotectant toxicity (2024)
-
Cleavage of Type I Collagen by Fibroblast Activation Protein-α Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion (2016)
-
Fibroblast‐Macrophage Interactions: Regulation by Modification of Extracellular Matrix (2015)
-
Fibroblast Activation Protein-α (2012)
-
Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions (2011)
-
Comparative characterization of UDP‐glucuronic acid (UDP‐GlcUA) binding‐site directed inhibitors with human UGT2B7 and 1A10. (2009)
-
The glucuronidation of native and oxidized estrogens can be effectively inhibited by compounds structurally related to UDP‐glucuronic acid in human recombinant UGT1A10 (2009)
-
Characterization of mutation in the 395 DQxD 398 motif of the glucuronic acid binding site in human UGT1A6: Comparison to UGT1A10 (2009)
-
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids (2009)
-
Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans (2009)
Collaboration Network
Top Collaborators
Grover P. Miller
University of Arkansas for Medical Sciences
5 shared publications
In database
- Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
- Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans
- The glucuronidation of native and oxidized estrogens can be effectively inhibited by compounds structurally related to UDP‐glucuronic acid in human recombinant UGT1A10
- Characterization of mutation in the 395 DQxD 398 motif of the glucuronic acid binding site in human UGT1A6: Comparison to UGT1A10
- Comparative characterization of UDP‐glucuronic acid (UDP‐GlcUA) binding‐site directed inhibitors with human UGT2B7 and 1A10.
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
5 shared publications
In database
- Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
- Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans
- The glucuronidation of native and oxidized estrogens can be effectively inhibited by compounds structurally related to UDP‐glucuronic acid in human recombinant UGT1A10
- Characterization of mutation in the 395 DQxD 398 motif of the glucuronic acid binding site in human UGT1A6: Comparison to UGT1A10
- Comparative characterization of UDP‐glucuronic acid (UDP‐GlcUA) binding‐site directed inhibitors with human UGT2B7 and 1A10.
Thomas J. Kelly
University of Arkansas for Medical Sciences
4 shared publications
In database
- Fibroblast Activation Protein-α
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
- Cleavage of Type I Collagen by Fibroblast Activation Protein-α Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion
- Fibroblast‐Macrophage Interactions: Regulation by Modification of Extracellular Matrix
Moshe Finel
University of Helsinki (FI)
4 shared publications
- Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
- The glucuronidation of native and oxidized estrogens can be effectively inhibited by compounds structurally related to UDP‐glucuronic acid in human recombinant UGT1A10
- Characterization of mutation in the 395 DQxD 398 motif of the glucuronic acid binding site in human UGT1A6: Comparison to UGT1A10
- Comparative characterization of UDP‐glucuronic acid (UDP‐GlcUA) binding‐site directed inhibitors with human UGT2B7 and 1A10.
Stacie M. Bratton
University of Arkansas for Medical Sciences (US)
3 shared publications
- Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
- The glucuronidation of native and oxidized estrogens can be effectively inhibited by compounds structurally related to UDP‐glucuronic acid in human recombinant UGT1A10
- Comparative characterization of UDP‐glucuronic acid (UDP‐GlcUA) binding‐site directed inhibitors with human UGT2B7 and 1A10.
Yan Huang
Winthrop Rockefeller Foundation (US)
2 shared publications
- Fibroblast Activation Protein-α
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Avis E. Simms
Cancer Research Center (US)
2 shared publications
- Fibroblast Activation Protein-α
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Jeffery H. Moran
University of Helsinki
2 shared publications
In database
- Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
- Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans
Steven R. Post
University of Arkansas for Medical Sciences
2 shared publications
In database
- Cleavage of Type I Collagen by Fibroblast Activation Protein-α Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion
- Fibroblast‐Macrophage Interactions: Regulation by Modification of Extracellular Matrix
Sophie Wang
Cancer Research Center (US)
1 shared publication
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Noel R. León
Cancer Research Center (US)
1 shared publication
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Barry Jones
vTv Therapeutics (United States) (US)
1 shared publication
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Nazneen Aziz
vTv Therapeutics (United States) (US)
1 shared publication
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
Drew R. Jones
Arkansas Department of Health (US)
1 shared publication
- Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans
Shane Z. Sullivan
Arkansas Department of Health (US)
1 shared publication
- Assessing Cytochrome P450 and UDP-Glucuronosyltransferase Contributions to Warfarin Metabolism in Humans
Similar Researchers
Based on overlapping research topics
Michael D. Richardson
University of Arkansas at Fayetteville
Pharmacological Effects and Toxicity Studies
Plant Stress Responses and Tolerance
Disease Models, Animal
Lisa M. Pence
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Metabolomics and Mass Spectrometry Techniques
Gabriel Gifford
University of Central Arkansas
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Health and Medical Research Impacts
Nicholas Rw
University of Arkansas at Little Rock
Pharmacological Effects and Toxicity Studies
Metabolomics and Mass Spectrometry Techniques
Health and Medical Research Impacts
Benjamin C. Wadsworth
University of Arkansas at Fayetteville
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Metabolomics and Mass Spectrometry Techniques
Rohini Donakonda
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Metabolomics and Mass Spectrometry Techniques